Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer-Reference-Cited by-同舟云学术

Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer

Published:2016-10-15 Issue:46 Volume:7 Page:76125-76139
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Lowes Lori E.¹,Goodale David²,Xia Ying²,Postenka Carl²,Piaseczny Matthew M.¹,Paczkowski Freeman²,Allan Alison L.¹³²⁴

Affiliation:

1. Department of Anatomy & Cell Biology, Schulich School of Medicine and Dentistry, Western University, London ON, Canada

2. London Regional Cancer Program, London Health Sciences Centre, London ON, Canada

3. Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London ON, Canada

4. Lawson Health Research Institute, London ON, Canada

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiplex Sensing of Biomarkers on the Cancer Cell Surface by an Epithelial-Mesenchymal Transition (EMT) Sensing Panel Enables Precise Differentiating of Cancer Cells at Various EMT Stages;Analytical Chemistry;2024-08-02

2. A novel high‐risk model identified by epithelial–mesenchymal transition predicts prognosis and radioresistance in rectal cancer;Molecular Carcinogenesis;2024-07-26

3. Molecular biomarkers in prostate cancer tumorigenesis and clinical relevance;Critical Reviews in Oncology/Hematology;2024-02

4. Models to study CTCs and CTC culture methods;International Review of Cell and Molecular Biology;2023

5. Circulating Tumor Cells as Biomarkers for Renal Cell Carcinoma: Ready for Prime Time?;Cancers;2022-12-31